ABSTRACT -A possible teratogenicity of multi-wall carbon nanotube (MWCNT) was assessed using ICR mice. MWCNTs were suspended in 2% carboxymethyl cellulose and given intraperitoneally or intratracheally to pregnant ICR mice on day 9 of the gestation. All fetuses were removed from the uterus on day 18 of the gestation, and were examined for external and skeletal anomalies. In the intraperitoneal study, various types of malformation were observed in all MWCNT-treated groups (2, 3, 4 and 5 mg/kg body weight, intraperitoneal). In contrast, such malformations were observed in groups given 4 or 5 mg/kg body weight, but not in that treated with 3 mg/kg in the intratracheal study. In either study, the number of litters having fetuses with external malformation and that of litters having fetuses with skeletal malformations were both increased in proportion to the doses of MWCNT. The present results are the first to report that MWCNT possesses the teratogenicity at least under the present experimental conditions. Mechanism(s) to result such malformations is yet unclear and further experiment is necessary.
INTRODUCTION
Carbon nanotube is a new form of the technological crystalline carbon and one of the most anticipated nanomaterials, because of its unique properties suitable for a variety of industrial products such as high strength materials, electronics and biomedical apparatuses (Martin and Kohli, 2003; Scott, 2005) . On the other hand, potential hazards and/or risk for humans of carbon nanotube has been concerned, and large efforts have been internationally being made to investigate and evaluate them (Lam et al., 2006; Pacurari et al., 2010; Hubbs et al., 2011) . Among those, a possible carcinogenicity has been concerned most, assuming the structural similarity between carbon nanotubes and asbestos. Takagi et al. (2008) have first reported that multi-wall carbon nanotube (MWCNT) induces mesotheliomas, when intraperitoneally administered to male p53 gene deficient mice. Shortly afterwards, Sakamoto et al. (2009) have demonstrated that the carcinogenicity of MWCNT is a universal event and not specific to mice or genetically modified animals, by showing the mesothelioma development in male intact (not genetically modified) rats, intrascrotally administered the same MWCNT. Since then, carcinogenicity of MWCNT has enthusiastically been being studied but the mechanism(s) of such carcinogenicity is yet not clearly understood. Because the damage to DNA, directly or indirectly, by MWCNT is to be evaluated by prenatal stage, a possible teratogenicity must be another big issue for the risk assessment of MWCNT. To the best of our knowledge there have been no reports dealing with this issue in the literature. In this content, the present study was conducted to assess a possible teratogenicity of MWCNT.
MATERIALS AND METHODS

Ethical consideration of the experiments
An experimental protocol was approved by the Experiments Regulation Committee and the Animal Experiment Committee of the Tokyo Metropolitan Institute of Public Health prior to its execution and monitored at every step during the experimentation for its scientific and 
Teratogenicity of multi-wall carbon nanotube (MWCNT) in ICR mice
Animals
Specific pathogen free Crlj:CD1(ICR) mice, 5 weeks old, were purchased from Charles River Japan Inc., Kanagawa, Japan and were sufficiently acclimatized before use. Mice were housed individually in plastic cage (180 x 305 x 110mm 3 ) with cedar chip bedding and free access to the standard diet CE2 (Nihon Clea, Inc., Tokyo, Japan) and water. The animal room was maintained at 23-25°C with a relative humidity of 50-60%, with 10 ventilation per hour (drawing fresh air through an HEPA-filter, 0.3 μm, 99.9% efficiency) and on a 12 hr light/dark cycle. At 8 to 13 weeks old, a nulliparous female was housed overnight with a male and the next morning the female was checked for the presence of a vaginal plug. The day when vaginal-plug formation was observed was regarded as day 0 of the gestation.
Test chemicals
The presently utilized test chemicals, MWCNT (MITSUI MWCNT-7; lot number, 060125-01k) was exactly identical to those used in the carcinogenicity studies in p53 gene deficient mice (Takagi et al., 2008) and in intact rats (Sakamoto et al., 2009) . MWCNT was suspended in 2% carboxymethyl cellulose sodium (CMCNa; Tokyo Chemical Industry Co., Ltd., Tokyo, Japan) solution at concentrations of 0.2, 0.3, 0.4 or 0.5 mg/ml for the intraperitoneal study to achieve a uniform administration volume of 10 ml/kg body weight. In the case of the intratracheal study, 3, 4 and 5 mg/ml suspensions were prepared to achieve a uniform administration volume of 1 ml/kg. The control (0 mg/kg body weight) animals were received 2% CMCNa solution, intraperitoneally or intratracheally, respectively. These suspensions as well as a vehicle 2% CMCNa solution were sterilized by an autoclave at 120°C for 20 min and vigorously mixed by hand shaking immediately prior to the administration.
Animal treatment and assessments
Two independent experiments were performed. In experiment 1, pregnant female mice were given a single intraperitoneal administration of MWCNT at dosages of 2, 3, 4 or 5 mg/kg body weight on day 9 of the gestation.
On the other hand, in experiment 2, mice were given a single intratracheal spray administration of 3, 4 or 5 mg/kg body weight using intratracheal aerosolizer (MicroSprayer Model IA-1B; Penn-Century, Inc., Philadelphia, PA, USA) on day 9 of the gestation.
In either experiment, body weights of mated females were measured daily, and clinical observations were recorded. All mice were killed on day 18 of the gestation under light ether anesthesia. The liver, lung, spleen, heart, kidney, thymus and tracheobronchial lymph node of each dam were removed and weighed. Peripheral blood was examined for the leukocyte counting by Sysmex KX-21NV. Blood films were made, stained by May/Grünwald;Giemsa and counted for the subtypes of leucocytes under the light microscopy.
The uterus was opened to examine for early and late fetal deaths, and to record the position of dead and live fetuses. The numbers of implantation sites and corpora lutea in the ovaries were also counted. Each live fetus was weighed and examined for external anomalies. Fetuses were fixed in 95% ethanol and stained with Alizarin Red S (Dawson, 1926) to examine skeletal anomalies.
Statistical analysis
Scheffe's multiple comparison was applied for the organ weights of dams, maternal body weights, number of implantations and live fetuses, and fetal body weights. The incidence of pregnant females and of litters with malformed fetuses, and the number of malformed fetuses were analyzed using the Chi square test. The rank sum test was used for data on the resorption and the percent incidence of malformations (Nishimura, 1976) . The trend test (cumulative X2 test) was performed to evaluate the significance of the development of malformations by the administered doses of MWCNT.
RESULTS
Experiment 1, the intraperitoneal study
The pregnant status is summarized in Table 1 . No animals died after the MWCNT administration. While most of the mated mice were gestated regardless to treatments, 1, 1, 6 and 6 pregnant mice, which were dosed 2, 3, 4 and 5 mg/kg body weight of MWCNT respectively, did not have any living fetuses on 18 day of the gestation. The statistical significances of this change were obtained in the 4-and 5-mg/kg groups. Similarly, the rates of early resorption of fetuses were significantly increased, with the number of live fetuses per litter being decreased, in these groups. In addition, the body weights of live fetuses were significantly lower in the 2-, 3-and 4-mg/kg groups, but not in the 5-mg/kg group, than in the control group. Figure 1 illustrates changes of the maternal body weight, of which increment was retarded by MWCNT with a dose-dependent tendency. The body and organ weights and leucocyte typing and counting data of dams are summarized in Table 2 . The final body weights were significantly decreased in the 4-and 5-mg/kg groups. The liver weight tended decreased in the dose groups but changes were not statistically significant. The weight of the spleen was significantly increased in the dose groups but no other adverse effect was evident. The numbers of total white blood cells, neutrophils, eosinophils and monocytes, lymphocytes as well but lesser degree, all tended increased in all MWCNT-treated groups. The statistical significances of these changes were obtained in the 3-mg/kg group for the total white blood cells and in 2-3-and 4-mg/kg groups for the neutro-and eosinophils.
The incidences of malformations were summarized in Table 3 . Various types of external and skeletal malformations, such as reduction deformity of limb, short or absent tail, cleft palate, fusion of vertebrae, hypophalangia and hyperphalangia, were observed not in the control group but in all MWCNT-treated groups. Whereas respective incidences of such malformations were a few, the ratio of litters with malformed fetuses, the percent incidence of malformations and the ratio of malformed fetuses were all increased in all MWCNT-treated groups, most of them being with the statistical significance. The trend test evaluated that the development of skeletal malformations by the administered doses of MWCNT was significant (p < 0.05). 
Skeletal malformation
Numbers of litters with malformed fetuses/examined (percentages in the parentheses) 0/10(0) 4/7(57.1)** 3/8(37.5)* 3/7(42.9)* 2/3(66.7)** Percent incidence of malformations # 0.0 ± 0.0 14.4 ± 18.1 11.1 ± 21.7 11.9 ± 19.2 40.0 ± 52.9 Numbers of malformed fetuses/examined 0/126 9/76*** 7/66*** 7/63*** 5/13*** Numbers of fetuses with fusion of ribs 0 3 1 2 0 fusion of vertebral bodies and arches 0 6 7 0 3 hypophalangia 0 2 2 3 2 hyperphalangia 0 0 0 2 0 # Calculated by averaging the percentage in each litter (i.e. numbers of malformations/fetuses) and shown as the means ± S.D. Asterisks represent that the values are significantly different from the control value (*, ** or *** indicating p < 0.05, 0.01 or 0.001, respectively).
Experiment 2, the intratracheal study
The pregnant status is summarized in Table 4 . No animals died after the MWCNT administration. Most of the treated mated mice were gestated, and all of them had living fetuses. The rates of early as well as late resorption of fetuses were increased in the 4-and 5-mg/kg groups, respectively, but these changes were not statistically significant because of a large dispersion. The numbers of live fetuses per litter in MWCNT-treated groups were well maintained, although slight decreases were seen in the 4-and 5-mg/kg groups. In contrast, the body weight of live fetuses was significantly lower in the 5-mg/kg group. Figure 2 illustrates changes of the maternal body weights, of which increment was retarded in the 5-mg/kg group. The body and organ weights, and leucocyte typing and counting data of dam are summarized in Table 5 . The final body weight was significantly decreased in the 5-mg/kg group. The weight of the lung and tracheobronchial lymph nodes tended increased in a dose-dependent tendency, and the statistical significance was achieved for the lung in the 5-mg/kg group. Lungs of dosed groups looked blackened. The numbers of total white blood cells tended increased in a dose-dependent tendency, and the statistical significance was achieved in the 4-and 5-mg/kg group, but the magnitude of this change was not so high. The numbers of all types of white blood cell looked increased in some MWCNT-treated group, but the changes were modest and lacked statistical significances.
The incidences of malformations were summarized in Table 6 . Various types of external and skeletal malformations, as seen in experiment 1, were observed not in the control group and scarcely in the 3-mg/kg group. In the 4-and 5-mg/kg groups, however, such malformations occurred frequently and significantly. Typical features of the reduction deformity of limb and the fusion of vertebrae and ribs are demonstrated in Figs. 3 and 4 , respectively. The ratio of litter with malformed fetuses, the percent incidence of malformations and the ratio of malformed fetuses were all increased in 4-and 5-mg/kg group, most of them being with the statistical significance.
DISCUSSION
The present results clearly elicit that MWCNT is teratogenic in mice, at least under the present experimental conditions. This is the first report demonstrate the teratogenicity of this nanomaterials. Also, there is no report on teratogenicity of other exogenous fibers such as single wall nanotubes, asbestos and glass fibers. It is sometimes difficult to judge teratogenicities of chemicals, especially when the maternal toxicity is present. Because the maternal toxicity was in fact observed in some MWCNT-treated groups of the present study, one might consider the malformation of the fetuses only reflected and thus did not necessarily indicate the "true" teratogenicity of MWC- NT. Malformations were, however, induced even in the 4-mg/kg group of the intratracheal study, in which MWC-NT did not apparently cause the maternal toxicity. In addition, the malformations induced by the MWCNT administration belonged to a reduction type, such as the reduction deformity of limbs and the short or absent tail. The malformations in this type have not been found among about 7,000 fetuses of ICR mice historically examined so far in our laboratory (Ogata et al., 1984 (Ogata et al., , 1987 (Ogata et al., , 1989 (Ogata et al., and 1999 . Also in other laboratories, the spontaneous incidence of the reduction deformity of limb of ICR mice is usually very low. For instance, the incidence of amelia and oligoductilia has both been reported to be 0.02% among 5,000 fetuses in another laboratory and no deformities have observed among 4,335 fetuses in another laboratory (Kameyama et al., 1980) . The malformations observed in this study are uncommon in merely by the maternal toxicity. It is thus safe to say that the teratogenicity of MWC-NT demonstrated in the present study is true with a biological signifi cance.
The reasons why we at fi rst conducted the intraperitoneal study and used very high doses were to avoid missing a teratogenicity of MWCNT, if it is present, under the experimental condition as sensitive as possible form the point of the hazard identifi cation. This is the same strategy that was adopted in the studies identifying the carcinogenic hazard of MWCNT (Sakamoto et al., 2009; Takagi et al., 2008) . The relatively severe maternal toxicity in the high doses is thus rather expected. Nevertheless, the present intraperitoneal study can demonstrate the teratogenicity of MWCNT as stated above, witch then led us to confi rm this hazard using a more human-relevant exposure route. In the intratracheal study, MWCNT was administered into the trachea of mice in a spray or mist shape, witch well mimics the most plausible human 19.9 ± 7.5 16.4 ± 5.3 18.9 ± 5.5 13.9 ± 8.9 Tracheobronchial lymph node (mg)
4.2 ± 3.6 6.8 ± 5.2 6.2 ± 4.3 8.7 ± 2.3 Leucocyte count (10 2 /μl) Total 37.5 ± 6.4 49.5 ± 11.3 51.6 ± 11.5* 51.3 ± 10.6* Lymphocyte 21.0 ± 4.4 30.0 ± 8.2 26.5 ± 7.4 22.5 ± 6.4 Neutrophil 14.7 ± 4.5 17.4 ± 9.7 20.3 ± 11.2 25.4 ± 11.5 Eosinophil 0.7 ± 0.9 1.1 ± 0.7 2.7 ± 2.5 1.6 ± 1.1 Monocyte 1.2 ± 0.7 1.0 ± 0. Vol. 37 No. 1 exposure situation of the inhalation. The highest dose of 5 mg/kg body weight must have been too high, because it caused the apparent maternal toxicity, and it agglomerated in the lung (data not shown). It is clearly indicated, however, that MWCNT is teratogenic, because the malformations in the fetuses were significantly induced by the middle dose of 4 mg/kg body weight that did not cause the apparent maternal toxicity.
It is known that methyl cellulose of a certain length has nephrotoxicity but, in this study, no adverse effect on kidney of dam given 2% CMCNa solution (control) nor suspension of MWCNT in 2% CMCNa (dosed groups) was observed.
Mechanisms underlying the teratogenicity of MWC-NT are still obscure. Sargent et al. (2009) has demonstrated that single-wall carbon nanotube induces aneuploidy in cultures primary and immortalized human airway epitherial cells by the disruption of the mitotic spindle. In that study, the association of nanotubes with cellular and mitotic tubulins as well as chromatins within the nuclei is demonstrated, and the similarity of nanotube bundles to microtubules in size of microtubules is considered to play roles, because it may make nanotubes incorporated into the mitotic spindle apparatus. Recently, Takahashi et al. (2010) has reported that MWCNT also induces polyploidy, suggesting that MWCNT may exert similar effects on microtubules to the situation of single-wall carbon nanotube. If it is a case, the disruption of the mitotic spindle and the fragmentation of the centrosomes may inhibit subsequent cell division, which results in the embryonic death in early phase and the malformation of the reduction type. Further studies are apparently warranted, and especially a passage of MWCNT through the placenta and the reach to the fetus should be evidenced.
Another possible factor involved in the teratogenicity may be the chronically persisting inflammation caused by the exposure to MWCNT, which is frequently considered to participate in the biological effects of nanomaterials (Takagi et al., 2008; Sakamoto et al., 2009; Erdely et al., 2009; Hubbs et al., 2011) . The present results of the increments of the numbers of leucocyte and related hemocytes, and of the weight of the spleen might support this possibility.
The present intratracheal study gives no-observedadverse-effect level (NOAEL) of 3 mg/kg body weight for external and skeletal malformations. Although the human exposure level of MWCNT has not as yet clearly determined, the interim report for the risk assessment of MWCNT by the National Institute of Advanced Industrial Science and Technology (AIST, 2009) roughly estimated the quantity of MWCNT exposure of workers as 0.53-6.20 μg/kg/day. Comparing with these values, the above NOAEL for external and skeletal malformations are approximately 480-5,660 times high. It is thus tentatively evaluated that the present results may not necessarily or immediately indicate a human risk. Needless to say, however, more detailed and careful investigations including those for the teratogenicity must be conducted to complete the risk assessment of MWCNT.
